Cargando…

Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine

We have earlier reported that a single dose of oral cholera vaccine (OCV) is protective in adults and children ≥5 years of age and sustained for 2 years. We enrolled participants (n = 240) from this study, between March-September 2017, over 3 years after receiving a primary single dose. Immune respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chowdhury, Fahima, Bhuiyan, Taufiqur Rahman, Akter, Afroza, Bhuiyan, Md Saruar, Khan, Ashraful Islam, Tauheed, Imam, Ahmed, Tasnuva, Ferdous, Jannatul, Dash, Pinki, Basher, Salima Raiyan, Hakim, Al, Lynch, Julia, Kim, Jerome H., Excler, Jean-Louis, Kim, Deok Ryun, Clemens, John D., Qadri, Firdausi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014297/ https://www.ncbi.nlm.nih.gov/pubmed/31879124 http://dx.doi.org/10.1016/j.vaccine.2019.12.034

Ejemplares similares

Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh
por: Chowdhury, Fahima, et al.
Publicado: (2020)

dmLT Adjuvant Enhances Cytokine Responses to T Cell Stimuli, Whole Cell Vaccine Antigens and Lipopolysaccharide in Both Adults and Infants
por: Akhtar, Marjahan, et al.
Publicado: (2021)

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh
por: Akter, Aklima, et al.
Publicado: (2019)

Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS)
por: Bhuiyan, Md Saruar, et al.
Publicado: (2019)

T helper cell responses in adult diarrheal patients following natural infection with enterotoxigenic Escherichia coli are primarily of the Th17 type
por: Akhtar, Marjahan, et al.
Publicado: (2023)

Determining clinical biomarkers to predict long-term SARS-CoV-2 antibody response among COVID-19 patients in Bangladesh
por: Ahmed, Tasnuva, et al.
Publicado: (2023)

Life-Course Approach to Vaccination in Bangladesh for Meeting the Health and Health-Related Sustainable Development Goals: A Commentary
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2021)

A snap-shot of a diarrheal epidemic in Dhaka due to enterotoxigenic Escherichia coli and Vibrio cholerae O1 in 2022
por: Tauheed, Imam, et al.
Publicado: (2023)

Covishield vaccine induces robust immune responses in Bangladeshi adults
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera
por: Kaisar, M. Hasanul, et al.
Publicado: (2021)

Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year
por: KINOSHITA, Yuta, et al.
Publicado: (2023)

Prevention of Smallpox by Vaccination and Revaccination
por: Seal, S. C.
Publicado: (1945)

Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses
por: Bhuiyan, Md Saruar, et al.
Publicado: (2020)

The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh
por: Ahmed, Tasnuva, et al.
Publicado: (2023)

A Few Words on Vaccination and Revaccination
por: Atkinson, F. Page
Publicado: (1871)

Is It Right to Vaccinate or Revaccinate Pregnant Women?
Publicado: (1871)

Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples
por: Dunmire, Chelsea N., et al.
Publicado: (2022)

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference
por: Islam, Md Taufiqul, et al.
Publicado: (2022)

Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine
por: Chac, Denise, et al.
Publicado: (2021)

Small-Pox—Vaccination and Revaccination—False Ideas
Publicado: (1872)

Safety of BCG vaccination and revaccination in healthcare workers
por: Villanueva, Paola, et al.
Publicado: (2023)

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine
por: Akter, Aklima, et al.
Publicado: (2021)

622. Increased IgA Coating of Gut Microbes After Administration of Killed, Whole-Cell Oral Cholera Vaccine
por: Weil, Ana, et al.
Publicado: (2018)

Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
por: Akhtar, Marjahan, et al.
Publicado: (2022)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

Prevention of Smallpox by Vaccination and Revaccination: A Critical Study
por: Seal, S. C.
Publicado: (1945)

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
por: Kaisar, M. Hasanul, et al.
Publicado: (2023)

Immunogenicity and Protection against Mycobacterium caprae Challenge in Goats Vaccinated with BCG and Revaccinated after One Year
por: Arrieta-Villegas, Claudia, et al.
Publicado: (2020)

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children
por: Uddin, Muhammad Ikhtear, et al.
Publicado: (2016)

Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh
por: Chowdhury, Fahima, et al.
Publicado: (2022)

Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19
por: Kombarova, S. Yu., et al.
Publicado: (2022)

Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh()
por: Khan, Ashraful Islam, et al.
Publicado: (2017)

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
por: Jackson, Lisa A, et al.
Publicado: (2009)

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh
por: Khan, Iqbal Ansary, et al.
Publicado: (2019)

Vaccination and Small-Pox in England and Other Countries, Showing That Compulsory Revaccination Is Necessary
por: Buist, John B.
Publicado: (1893)

Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
por: Kelly, Meagan, et al.
Publicado: (2023)

Antigen-Specific Memory B-cell Responses to Enterotoxigenic Escherichia coli Infection in Bangladeshi Adults
por: Alam, Mohammad Murshid, et al.
Publicado: (2014)

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
por: Qadri, Firdausi, et al.
Publicado: (2020)

Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial
por: Khan, Ashraful Islam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_01u8jcaqi99ps5ivl47vsjqn25